MediWound Ltd. (MDWD)
NASDAQ: MDWD · Real-Time Price · USD
17.82
+0.60 (3.48%)
At close: Feb 6, 2026, 4:00 PM EST
17.79
-0.03 (-0.17%)
After-hours: Feb 6, 2026, 4:10 PM EST
MediWound Market Cap
MediWound has a market cap or net worth of $228.09 million as of February 6, 2026. Its market cap has increased by 14.82% in one year.
Market Cap
228.09M
Enterprise Value
177.27M
1-Year Change
14.82%
Ranking
Category
Stock Price
$17.82
Market Cap Chart
Since March 20, 2014, MediWound's market cap has decreased from $262.70M to $228.09M, a decrease of -13.17%. That is a compound annual growth rate of -1.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 5, 2026 | 220.79M | -6.72% |
| Dec 31, 2025 | 236.68M | 23.23% |
| Dec 31, 2024 | 192.06M | 104.85% |
| Dec 29, 2023 | 93.76M | 19.44% |
| Dec 30, 2022 | 78.50M | 22.08% |
| Dec 31, 2021 | 64.30M | -36.14% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Protalix BioTherapeutics | 234.03M |
| Shattuck Labs | 225.91M |
| Cabaletta Bio | 224.30M |
| Palisade Bio | 223.50M |
| Climb Bio | 222.01M |
| Heron Therapeutics | 221.87M |
| Nuvectis Pharma | 216.45M |
| Inhibikase Therapeutics | 216.12M |